Radnor Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $326K | Sell |
4,170
-550
| -12% | -$44.4K | 0.05% | 266 |
|
|
2026
Q1 | $409K | Hold |
4,720
| – | – | 0.06% | 241 |
|
|
2025
Q4 | $453K | Sell |
4,720
-500
| -10% | -$48.6K | 0.07% | 234 |
|
|
2025
Q3 | $497K | Hold |
5,220
| – | – | 0.08% | 232 |
|
|
2025
Q2 | $455K | Sell |
5,220
-120
| -2% | -$10.2K | 0.07% | 233 |
|
|
2025
Q1 | $480K | Buy |
5,340
+65
| +1% | +$5.82K | 0.08% | 227 |
|
|
2024
Q4 | $421K | Sell |
5,275
-1,800
| -25% | -$156K | 0.07% | 244 |
|
|
2024
Q3 | $637K | Buy |
7,075
+1,300
| +23% | +$109K | 0.09% | 215 |
|
|
2024
Q2 | $455K | Buy |
5,775
+231
| +4% | +$18.9K | 0.14% | 117 |
|
|
2024
Q1 | $483K | Sell |
5,544
-306
| -5% | -$26.1K | 0.08% | 224 |
|
|
2023
Q4 | $482K | Sell |
5,850
-697
| -11% | -$53.1K | 0.09% | 222 |
|
|
2023
Q3 | $513K | Sell |
6,547
-2,254
| -26% | -$189K | 0.1% | 205 |
|
|
2023
Q2 | $775K | Hold |
8,801
| – | – | 0.33% | 65 |
|
|
2023
Q1 | $710K | Buy |
8,801
+310
| +4% | +$25.3K | 0.19% | 121 |
|
|
2022
Q4 | $680K | Sell |
8,491
-250
| -3% | -$20.3K | 0.17% | 139 |
|
|
2022
Q3 | $706K | Sell |
8,741
-300
| -3% | -$27K | 0.2% | 127 |
|
|
2022
Q2 | $811K | Hold |
9,041
| – | – | 0.22% | 123 |
|
|
2022
Q1 | $1M | Sell |
9,041
-600
| -6% | -$63.4K | 0.25% | 115 |
|
|
2021
Q4 | $997K | Sell |
9,641
-200
| -2% | -$23.2K | 0.25% | 101 |
|
|
2021
Q3 | $1.23M | Sell |
9,841
-50
| -0.5% | -$6.47K | 0.73% | 26 |
|
|
2021
Q2 | $1.23M | Hold |
9,891
| – | – | 0.41% | 62 |
|
|
2021
Q1 | $1.17M | Hold |
9,891
| – | – | 0.38% | 65 |
|
|
2020
Q4 | $1.16M | Hold |
9,891
| – | – | 0.33% | 67 |
|
|
2020
Q3 | $1.03M | Buy |
9,891
+1,471
| +17% | +$148K | 0.34% | 68 |
|
|
2020
Q2 | $777K | Buy |
8,420
+100
| +1% | +$9.59K | 0.28% | 80 |
|
|
2020
Q1 | $750K | Hold |
8,320
| – | – | 0.31% | 75 |
|
|
2019
Q4 | $944K | Hold |
8,320
| – | – | 0.29% | 80 |
|
|
2019
Q3 | $904K | Hold |
8,320
| – | – | 0.3% | 79 |
|
|
2019
Q2 | $810K | Hold |
8,320
| – | – | 0.27% | 85 |
|
|
2019
Q1 | $758K | Hold |
8,320
| – | – | 0.25% | 91 |
|
|
2018
Q4 | $757K | Hold |
8,320
| – | – | 0.27% | 83 |
|
|
2018
Q3 | $818K | Hold |
8,320
| – | – | 0.26% | 89 |
|
|
2018
Q2 | $712K | Hold |
8,320
| – | – | 0.26% | 91 |
|
|
2018
Q1 | $667K | Hold |
8,320
| – | – | 0.23% | 93 |
|
|
2017
Q4 | $672K | Sell |
8,320
-580
| -7% | -$46.5K | 0.22% | 100 |
|
|
2017
Q3 | $790K | Hold |
8,900
| – | – | 0.27% | 83 |
|
|
2017
Q2 | $790K | Hold |
8,900
| – | – | 0.27% | 83 |
|
|
2017
Q1 | $717K | Sell |
8,900
-675
| -7% | -$52.7K | 0.24% | 90 |
|
|
2016
Q4 | $682K | Buy |
+9,575
| New | +$752K | 0.23% | 89 |
|
Other funds holding MDT
Radnor Capital Management's MDT Position: Q2 2026 in Review
Radnor Capital Management reduced its Medtronic (MDT) stake by 12% in Q2 2026, selling an estimated $44.4K and leaving 4,170 shares worth $326K. The position accounts for 0.05% of the portfolio, ranked #266.
Radnor Capital Management first reported a position in MDT in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.23M in Q3 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Radnor Capital Management held 4,170 shares of Medtronic worth $326K as of Q2 2026.
- Radnor Capital Management sold 550 Medtronic shares in Q2 2026, an estimated $44.4K.
- Medtronic made up 0.05% of Radnor Capital Management's portfolio in Q2 2026, its #266 holding.
- Radnor Capital Management first reported a position in Medtronic in Q4 2016 and has held it in 39 quarters since.
- Radnor Capital Management's Medtronic position peaked at $1.23M in Q3 2021.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Radnor Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.